The European Medicines Agency is scheduled to announce today whether AstraZeneca and the University of Oxford in the UK have approved conditional marketing of the COVID-19 vaccine.
The European Medicines Agency is expected to recommend conditional marketing approval of the vaccine after an expert evaluation meeting held today.
The European Commission, the executive branch of the European Union, can make a final decision within a few hours and, once officially approved, can begin vaccination within the EU member states.
The AstraZeneca-Oxford University vaccine will be the third Corona 19 vaccine available in the European Union following the Corona 19 vaccine developed by Pfizer-Germany Bioentech and Modena.
The EU’s conditional marketing approval is a process to quickly respond to public health-threatening emergencies such as COVID-19, allowing pharmaceuticals to be sold for one year in 27 member states and can be renewed annually.
The European Union previously approved the COVID-19 vaccine jointly developed by Pfizer-Bioentech on the 21st of last month following the recommendation of the European Medicines Agency, and earlier this month approved the conditional sale of Modena vaccine in the European Union.